The Quantellect read.As of Nov 19, 2026, 6 active firms cover National Health Investors Inc: 4 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $68.00 to $94.00, so the covering firms are broadly aligned. The average target of $81.67 sits 31% above the current $62.47. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.73 next quarter toward $3.03 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Buy
Strong Buy00%
Buy467%
Neutral233%
Sell00%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$81.67
+30.7% upside
Average target across 6 active firms as of Nov 19, 2026 vs $62.47 current
Highest Target$94.00
Average Target$81.67
Lowest Target$68.00
Detailed analyst forecasts for NHI
Showing 1–7 of 7 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 4 of 6 active firms rate NHI a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
NHI EPS & revenue forecast
EPS · NEXT QUARTER
$0.73
Range $0.73 – $0.73 · 1 analysts · -5% YoY
Next period, 1 analysts expect National Health Investors Inc to earn $0.73 a share (range $0.73 – $0.73), versus $0.77 a year earlier. Full-year consensus is $14.09, growing to $3.03 the year after.
REVENUE · NEXT QUARTER
$119.8M
Range $112.6M – $137.5M · 1 analysts · +4% YoY
Revenue is expected to reach $119.8M (range $112.6M – $137.5M), +4.0% year-over-year. Full-year consensus is $456.2M, rising to $498.7M next year.
Top analysts covering National Health Investors Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NHI.
#1
John Kilichowski
Wells Fargo · Rank #103
Neutral
$78.00+24.9% to target
Overall win rate
50%
+ Follow
#2
Michael Lewis
Truist Securities · Rank #243
Buy
$80.00+28.1% to target
Overall win rate
43%
+ Follow
#3
FG
Farrell Granath
Bank of America Securities
Buy
$86.00+37.7% to target
Coverage
—
+ Follow
#4
Richard Anderson
Cantor Fitzgerald
Buy
$90.00+44.1% to target
Coverage
—
+ Follow
#5
Omotayo Okusanya
Deutsche Bank
Neutral
$80.00+28.1% to target
Coverage
—
+ Follow
NHI stock forecast FAQ
What is NHI's average 12-month price target?+
The 6 active firms with a live target average $81.67 for National Health Investors Inc over the next 12 months, ranging from a $94.00 high to a $68.00 low, as of Nov 19, 2026.
Is NHI stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 6 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for NHI?+
The Street-high target is $94.00 (Cantor Fitzgerald), and the Street-low is $68.00 (Wells Fargo). The average of all 6 active-firm targets is $81.67.
How many active Wall Street firms cover NHI?+
6 active firms have a recognized rating on National Health Investors Inc as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering NHI?+
Among analysts who currently cover NHI, John Kilichowski of Wells Fargo has the strongest overall Quantellect track record (Rank #103). Their current call is Neutral with a $78.00 target.
What is National Health Investors Inc's projected EPS for next quarter?+
The consensus estimate is $0.73 per share (range $0.73 – $0.73) across 1 analysts. Full-year EPS is projected at $14.09, rising to $3.03 the following year.
How much revenue is National Health Investors Inc expected to report next quarter?+
Consensus revenue is $119.8M (range $112.6M – $137.5M). Full-year revenue is projected at $456.2M, growing to $498.7M next year.
Have analysts been upgrading or downgrading NHI lately?+
As of Nov 19, 2026, 4 of 6 active firms rate NHI a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NHI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.